Medtronic PLC

MDT Healthcare Medical Devices

Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.

94.75 0.70 −0.73%
Market cap
$122.1B
P/E
23.2×
Fwd P/E
18.7×
Dividend yield
3.02%
F-score
7/9
Altman Z
2.73
Beneish M
−2.58
Dividend safety
61/100

Medtronic PLC (MDT) Free cash flow

Alert me on Free cash flow

Medtronic PLC's free cash flow for fiscal 2026 was $5.4B, unchanged from fiscal 2025. Over the twelve months to 31 July 2026 it was $6.1B. Over the past ten years it has ranged from $3.6B (fiscal 2018) to $6.0B (fiscal 2020); the current reading is higher than 67% of that period. Medtronic PLC ranks 2nd of 149 Medical Devices companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2026 $5.4B 4.65%
FY2025 $5.2B (0.29%)
FY2024 $5.2B 13.54%
FY2023 $4.6B (23.39%)
FY2022 $6.0B 22.37%
FY2021 $4.9B (18.87%)
FY2020 $6.0B 2.52%
FY2019 $5.9B 62.42%
FY2018 $3.6B (35.73%)
FY2017 $5.6B 34.85%

Quarterly newest first

Period Free cash flow Change
Jul 2026 $1.3B (38.13%)
Apr 2026 $2.1B (9.35%)
Jan 2026 $2.3B 403.28%
Oct 2025 $457.0M (21.75%)
43 more quarters

Against its own ten years

Low $3.6B High $6.0B
Ten-year median $5.2B
Current reading's percentile 67

Free cash flow against peers

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on MDT